Anika Therapeutics reported $-18137000 in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -57.4M 18.17M
Acorda Therapeutics ACOR:US $ -19.54M 0M
Adamas Pharmaceuticals ADMS:US $ -18.27M 6.36M
Agenus AGEN:US $ -37.73M 0M
Agios Pharmaceuticals AGIO:US $ -97.66M 1.32M
Anika Therapeutics ANIK:US $ -18.14M 0M
Arrowhead Research ARWR:US $ -20.73M 27.7M
Chemocentryx CCXI:US $ -29.88M 0M
Clovis Oncology CLVS:US $ -99.38M 20.69M
Dicerna Pharmaceuticals DRNA:US $ -36.59M 14.74M
Enanta Pharmaceuticals ENTA:US $ -11.62M 7.01M
Flexion Therapeutics FLXN:US $ -19647000 0
Halozyme Therapeutics HALO:US $ 73.25M 36.98M
Heron Therapeutics HRTX:US $ -62.28M 4.05M
Immunogen IMGN:US $ 31.39M 53.76M
Insmed INSM:US $ -101592000 38.25M
Integra Lifesciences IART:US $ 83.14M 1.17M
Intrexon XON:US $ -0.92M 0M
Karyopharm Therapeutics KPTI:US $ -43359000 10.09M
Ligand Pharmaceuticals LGND:US $ 33.04M 10.67M
Macrogenics MGNX:US $ -2.09M 33.96M
Merit Medical Systems MMSI:US $ 37.88M 3.78M
Peregrine Pharmaceuticals PPHM:US $ 2.21M 0M
Rigel Pharmaceuticals RIGL:US $ -19.24M 0M
Sangamo Biosciences SGMO:US $ -40.57M 39.3M
Sanofi SAN:FP € 1962M 997M
Stryker SYK:US $ 1167M 312.89M
Surmodics SRDX:US $ 0.45M 1.98M
Veracyte VCYT:US $ -8.04M 3.92M
Xencor XNCR:US $ -13.69M 1.14M
Zimmer Biomet Holdings Inc ZBH:US $ 518.6M 45.3M